Vidaza Side Effects
Compare Vidaza Side Effects
Post Your Vidaza Side Effect and Help Community!
List of Vidaza Side Effects reported to Patientsville
Detailed Vidaza Side Effects reported to Patientsville
Vidaza Side Effects reported to FDA
Quick-Add Your Side Effect
Substances toxic to Health
Side Effects SurveyVidaza Side Effects summary
Total Vidaza reports: 146.Vidaza FDA safety alerts: No.
Reported deaths: 55 Reported hospitalizations: 112.
How to use Vidaza ?.
Ask a Health Expert about Vidaza or Ask Patient Community about Vidaza.
Post a question or leave a comment:
Comments to date: 1. Page 1 of 1.
John P. Location unknown | 8:33pm on Tuesday, September 23rd, 2008 |
My 73 yo mother was diagnosed with myelodysplasia three months ago. After failing to respond to the growth factor treatment, her doctor began administering Vidaza, using the 5 day cycle. After the 3rd shot, she was treated for dehydration. After the ... read more » | |
Vidaza Poll Results
Have you experienced Vidaza side effects?| Yes, Severe |  67% |
| Yes, Mild | 33% |
| Yes, Minor | 0% |
| No | 0% |
Recent Questions and Answers about Vidaza
Is 'azacytidine' sold as medicine for cancer treatment?
Vidaza Side Effects reported on Patientsville.com
None reported at this time.Vidaza FDA reported side effects and reactions
| 2008 |
|---|
| ABDOMINAL PAIN |
| 2007 |
|---|
| ANAEMIA, ATRIAL FIBRILLATION |
| 2006 |
|---|
Vidaza Side Effects reported to FDA
Showing 1-40 of 146 Next >
Vidaza Side Effects Report #5207122-6Consumer or non-health professional from UNITED STATES reported VIDAZA problem on Dec 27, 2006. Female patient, 86 years of age, weighting 126.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: chest pain
, gastrooesophageal reflux disease. VIDAZA dosage: unknown. During the same period patient was treated with VERAPAMIL, PREDNISONE. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5213880-7
VIDAZA problem was reported by a Physician from UNITED STATES on Jan 05, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation
, culture urine positive, enterococcal infection, neutropenic sepsis, no therapeutic response, pericardial effusion, pericarditis, sinus tachycardia, staphylococcal infection. VIDAZA dosage: 132.75 MG (75 MG/M2, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL. Patient was hospitalized. Patient died on 01/08/2007.Vidaza Side Effects Report #5225220-8
Consumer or non-health professional from PHILIPPINES reported VIDAZA problem on Jan 23, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: arrhythmia
. VIDAZA dosage: unknown. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.Vidaza Side Effects Report #5228738-7
VIDAZA problem was reported by a Physician from UNITED STATES on Jan 19, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation
, cardiopulmonary failure, culture urine positive, enterococcal infection, hypotension, neutropenic sepsis, no therapeutic response, pericarditis, sinus tachycardia. VIDAZA dosage: 132.75 MG (75 MG/M2,DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 01/08/2007.Vidaza Side Effects Report #5229612-2
Physician from UNITED STATES reported VIDAZA problem on Jan 18, 2007. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: coma, dialysis
, haemoglobin decreased, haemorrhage, hypotension, leukopenia, pneumonia . VIDAZA dosage: 75 MG/M2 (130 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with COUMADIN, LIPITOR, DIGITEX, ATACAND, ARANESP. Patient was hospitalized. Patient died on 02/16/2006.Vidaza Side Effects Report #5237948-4
VIDAZA problem was reported by a Physician from PHILIPPINES on Feb 01, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, arrhythmia
, asthenia, disease progression, platelet count decreased. VIDAZA dosage: 50 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.Vidaza Side Effects Report #5241458-8
Physician from UNITED STATES reported VIDAZA problem on Jan 26, 2007. Female patient, 47 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: fungal infection, lung neoplasm, pulmonary embolism
. VIDAZA dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. Patient recovered.Vidaza Side Effects Report #5286019-X
VIDAZA problem was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 79 years of age, weighting 181.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: atelectasis, hypotension, hypoxia, pleural effusion, productive cough, renal failure, sepsis
, sputum discoloured, sputum purulent. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with METFORMIN, ASPIRIN, DOXYCYCLINE, GUAIFENESIN, POTASSIUM. Patient was hospitalized. Patient died on 03/17/2007.Vidaza Side Effects Report #5293978-8
Physician from UNITED STATES reported VIDAZA problem on Mar 23, 2007. Female patient, 47 years of age, weighting 135.4 lb, was diagnosed with myelodysplastic syndrome, decreased appetite and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: decreased appetite, fungal infection, hepatic infection, lung neoplasm, pulmonary embolism
. VIDAZA dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with MEGACE, ATIVAN, VFEND, CASPOFUNGIN. Patient recovered.Vidaza Side Effects Report #5343436-7
VIDAZA problem was reported by a Physician from UNITED KINGDOM on May 17, 2007. Male patient, 55 years of age, weighting 188.7 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: blood culture positive, blood pressure systolic decreased, condition aggravated, neutropenic sepsis, pseudomonas infection, refusal of treatment by patient, sputum culture positive, white blood cell count decreased. VIDAZA dosage: 75 MG/M2 (150 MG ONCE DAILY X FIVE DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROATE, THEOPHYLLINE, ATRA, VALACYCLOVIR, METRONIDAZOLE, ADCORTYL IN ORAL BASE, AMILORIDE. Patient was hospitalized. Patient died on 05/09/2007.
Vidaza Side Effects Report #5354898-3
Physician from UNITED STATES reported VIDAZA problem on June 04, 2007. Male patient, 79 years of age, weighting 199.1 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood potassium decreased, crepitations, decreased appetite, discomfort, dyspnoea exertional, fatigue. VIDAZA dosage: 50 MG/M2 (DAYS 1 THROUGH 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with LASIX, COLACE, SENOKOT, NEURONTIN, PENICILLIN. Patient died on 04/26/2007.
Vidaza Side Effects Report #5367782-6
VIDAZA problem was reported by a Physician from UNITED KINGDOM on June 04, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, haemolysis, nausea, polychromasia, red blood cell spherocytes present. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Patient recovered.
Vidaza Side Effects Report #5049253-X
Pharmacist from UNITED STATES reported VIDAZA problem on June 26, 2006. Male patient was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: splenic rupture, splenomegaly. VIDAZA dosage: unknown. Patient recovered.
Vidaza Side Effects Report #5060546-2
VIDAZA problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, haemorrhage, pneumonia
, sepsis . VIDAZA dosage: unknown. During the same period patient was treated with LIPITOR, ATIVAN. Patient was hospitalized. Patient died on 02/16/2006.Vidaza Side Effects Report #5071698-2
Physician from UNITED STATES reported VIDAZA problem on July 27, 2006. Male patient, 58 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: colitis, ileus, intestinal obstruction, pancreatitis. VIDAZA dosage: 75 MG/M2 (140 MG) SUBCUTANEOUS. During the same period patient was treated with ACETAMINOPHEN, PROCHLORPERAZINE MALEATE, IPRATROPIUM. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5077823-1
VIDAZA problem was reported by a Physician from UNITED STATES on July 24, 2006. Female patient, 61 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: gastric perforation, septic shock. VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with METOPROLOL. Patient was hospitalized. Patient died on 07/11/2006.
Vidaza Side Effects Report #5084852-0
Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF reported VIDAZA problem on Aug 03, 2006. Female patient, 74 years of age, weighting 101.4 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: asthenia, diarrhoea, epistaxis, febrile neutropenia, hyponatraemia, meningitis bacterial, pancytopenia, pneumonia
. VIDAZA dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with FOSAMAX. Patient was hospitalized. Patient died on 05/14/2006.Vidaza Side Effects Report #5097684-4
VIDAZA problem was reported by a Physician from THAILAND on Aug 24, 2006. Male patient, 33 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: infection, nausea, neutropenia, vomiting. VIDAZA dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LPRC, ONDANSETRON. Patient was hospitalized. Patient died on 07/01/2006.
Vidaza Side Effects Report #5120147-4
Physician from THAILAND reported VIDAZA problem on Sept 14, 2006. Male patient, 33 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, haematocrit decreased, lobar pneumonia, lymphocyte percentage increased, nausea, neutropenia, platelet count decreased, septic shock. VIDAZA dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with LPRC, ONDANSETRON. Patient was hospitalized. Patient died on 07/01/2006.
Vidaza Side Effects Report #5128618-1
VIDAZA problem was reported by a Physician from UNITED STATES on Sept 26, 2006. Male patient, 51 years of age, weighting 244.9 lb, was diagnosed with metastatic malignant melanoma and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: arthropod sting, iritis, local swelling. VIDAZA dosage: 75 MG/M2 (DAILY X 3 DAYS EVERY 2 WEEKS), SUBCUTANEOUS. During the same period patient was treated with INTERFERON, AMBIEN CR, FERROUS SULPHATE, PERCOCET, SYNTHROID. Patient recovered.
Vidaza Side Effects Report #5144297-1
Consumer or non-health professional from UNITED STATES reported VIDAZA problem on Oct 18, 2006. Female patient, 71 years of age, weighting 150.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, caecitis, vomiting. VIDAZA dosage: unknown. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5145543-0
VIDAZA problem was reported by a Physician from UNITED STATES on Oct 17, 2006. Female patient, 79 years of age, weighting 183.4 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, dilatation atrial, epistaxis, thrombocytopenia, ventricular extrasystoles, ventricular hypertrophy. VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, SPIRIVA, ADVAIR DISKUS, FLONASE, ALLEGRA, ZOLOFT, FOLATE, METAMUCIL. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5146393-1
Physician from UNITED STATES reported VIDAZA problem on Oct 19, 2006. Male patient, 75 years of age, weighting 182.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: amyotrophic lateral sclerosis
, bedridden, blood product transfusion dependent, gait disturbance, nerve injury, polyneuropathy. VIDAZA dosage: unknown. During the same period patient was treated with SIMVASTATIN. Patient recovered.Vidaza Side Effects Report #5154593-X
VIDAZA problem was reported by a Physician from ITALY on Oct 26, 2006. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, coma hepatic, hepatic failure, hepatic necrosis, pneumonia
. VIDAZA dosage: 60 MG/M2 (100 MG, DAILY X 8 DAYS, WITHOUT WEEKEND DOSING), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, TRETINOIN, DANAZOLE. Patient died.Vidaza Side Effects Report #5166006-2
Health Professional from UNITED STATES reported VIDAZA problem on Nov 16, 2006. Female patient, 47 years of age, weighting 115.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: pancreatitis. VIDAZA dosage: 56 MG/M2 (88 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with ZOLOFT, QUINAPRIL, PRAVASTATIN, NISOLDIPINE, LORATADINE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5166385-6
VIDAZA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2006. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: haemorrhage, pneumonia
, renal failure, sepsis . VIDAZA dosage: unknown. Patient was hospitalized. Patient died on 02/01/2006.Vidaza Side Effects Report #5170131-X
Physician from UNITED STATES reported VIDAZA problem on Nov 16, 2006. Female patient, 47 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: atelectasis, cardiac arrest
, carotid artery aneurysm, carotid artery atheroma, constipation , electrocardiogram qt corrected interval prolonged, febrile neutropenia, hypokalaemia, hypomagnesaemia. VIDAZA dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with AMBISOME, NORFLOXACIN, ZOFRAN, REGLAN, BENADRYL, PROTONIX, TYLENOL. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5178223-6
VIDAZA problem was reported by a Physician from KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF on Nov 24, 2006. Female patient, 68 years of age, weighting 72.75 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: ascites, bone marrow failure, nausea, peritonitis, pneumonia
, vomiting. VIDAZA dosage: 75 MG/M2 (DAILY X 7. Patient was hospitalized. Patient died on 11/18/2006.Vidaza Side Effects Report #5178225-X
Physician from PHILIPPINES reported VIDAZA problem on Nov 23, 2006. Male patient was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: disease progression. VIDAZA dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. Patient died.
Vidaza Side Effects Report #5187668-X
VIDAZA problem was reported by a Physician from UNITED STATES on Nov 28, 2006. Male patient, 75 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: bacterial infection, bronchial obstruction, pancytopenia, pneumonia fungal, sputum culture positive. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with FORTAZ, FLEXERIL, AVODART, LOTEMAX, PROTONIX, ZOCOR, BENADRYL, TYLENOL. Patient was hospitalized. Patient died on 12/05/2006.
Vidaza Side Effects Report #5189382-3
Health Professional from FRANCE reported VIDAZA problem on Dec 01, 2006. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, bone marrow transplant, bronchopulmonary aspergillosis, condition aggravated, febrile bone marrow aplasia, pancytopenia. VIDAZA dosage: 75 MG/M2 (DAILY X 6 DAYS), SUBCUTANEOUS. During the same period patient was treated with DANATROL, ARANESP. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5191605-1
VIDAZA problem was reported by a Physician from ITALY on Dec 04, 2006. Female patient, 66 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, coagulopathy, coma hepatic, condition aggravated, hepatic failure, hepatic necrosis, hepatotoxicity, international normalised ratio increased, neutrophil count decreased. VIDAZA dosage: 60 MG/M2 (100 MG, DAILY X 8 DAYS, WITHOUT WEEKEND DOSING), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, DANAZOLE, TRETINOIN. Patient died on 10/24/2006.
Vidaza Side Effects Report #5193880-6
Physician from UNITED STATES reported VIDAZA problem on Dec 19, 2006. Male patient, 74 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: hypotension, hypoxia, interstitial lung disease, supraventricular tachycardia. VIDAZA dosage: (85 MG, DAILY X 10 DAYS), SUBCUTANEOUS. During the same period patient was treated with TOPROL, FOLTX, ZOLOFT, CARDURA, ZYRTEC, ARANESP. Patient was hospitalized. Patient died on 10/23/2006.
Vidaza Side Effects Report #5195824-X
VIDAZA problem was reported by a Physician from UNITED STATES on Dec 14, 2006. Female patient, 69 years of age, weighting 158.0 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: asthenia, bacteria stool identified, bacterial infection, blood pressure decreased, catheter sepsis, condition aggravated, heart rate decreased, heart rate increased, nausea. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with ZOLOFT, XANAX, ASCORBIC ACID, IRON, CYANOCOBALAMIN, SPIRIVA, ALBUTEROL. Patient was hospitalized. Patient died on 12/12/2006.
Vidaza Side Effects Report #5380511-5
Physician from UNITED KINGDOM reported VIDAZA problem on June 21, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: anaemia, nausea, polychromasia, red blood cell spherocytes present. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS),INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Patient recovered.
Vidaza Side Effects Report #5385214-9
VIDAZA problem was reported by a Physician from UNITED KINGDOM on June 22, 2007. Male patient, 68 years of age, weighting 154.3 lb, was diagnosed with myelodysplastic syndrome and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: abscess intestinal. VIDAZA dosage: (75 MG/M2, SUBCUTANEOUS. During the same period patient was treated with CIPROFLOXACIN, NYSTATIN, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5397276-3
Physician from GERMANY reported VIDAZA problem on July 09, 2007. Male patient, 55 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis of nausea and vomiting and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: aggression. VIDAZA dosage: 75 MG/M2 (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with ONDANSETRON. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5398952-9
VIDAZA problem was reported by a Pharmacist from UNITED STATES on July 24, 2007. Female patient, 81 years of age, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: pancytopenia. VIDAZA dosage: unknown. During the same period patient was treated with TYLENOL, HEPARIN, AZTREONAM, CIPROFLOXACIN, ALBUTEROL, IPRATROPIUM BROMIDE, BACTRIM, VANCOMYCIN. Patient was hospitalized. Patient died on 04/04/2006.
Vidaza Side Effects Report #5402040-2
Physician from FRANCE reported VIDAZA problem on July 12, 2007. Male patient, 55 years of age, weighting 220.5 lb, was diagnosed with myelodysplastic syndrome, thrombosis prophylaxis, pyrexia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: bacterial infection, catheter related infection, culture urine positive, escherichia infection, international normalised ratio increased, pneumonia klebsiella, sepsis
. VIDAZA dosage: 120 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with PREVISCAN, AMOXICILLIN, ATENOLOL. Patient was hospitalized. Patient recovered.Vidaza Side Effects Report #5413136-3
VIDAZA problem was reported by a Physician from UNITED STATES on July 26, 2007. Female patient, 78 years of age, weighting 140.2 lb, was diagnosed with acute myeloid leukaemia and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, thrombocytopenia, urinary tract infection. VIDAZA dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, ATENOLOL. Patient was hospitalized. Patient recovered.
Showing 1-40 of 146 Next >
